Stereotactic Body Radiation Therapy (SBRT)

Stereotactic body radiation therapy (SBRT), or stereotactic ablative radiotherapy, is a type of radiation therapy that precisely targets a tumor with high doses of radiation by using several beams of various intensities aimed at different angles.

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

News | Quality Assurance (QA) | July 08, 2019
July 8, 2019 — At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio,...
Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones
News | Radiation Therapy | July 05, 2019
July 5, 2019 — Aktina Medical announced that Elekta Instrument AB, based in Sweden, will offer and distribute the...
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
May 28, 2019 — Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Imaging | April 23, 2019
April 23, 2019 — Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
January 31, 2019 — The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can...
SBRT Considered Safe Treatment Option for Patients With Multiple Metastases
News | Stereotactic Body Radiation Therapy (SBRT) | November 01, 2018
November 1, 2018 — The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy (...
Overall survival of metastatic patients with SABR presented at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018
News | Radiation Oncology | October 30, 2018
October 30, 2018 — In the first randomized, phase II clinical trial of its kind, researchers have shown that an...
ASTRO 2018 Radiation Therapy Clinical Trials. #ASTRO2018 #ASTRO18 #ASTRO
Feature | ASTRO | October 30, 2018
October 30, 2018 — The American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting included 10 top-rated...
Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018. #ASTRO #ASTRO18 #ASTRO2018

Amar U. Kishan, M.D., presents data about stereotactic body radiation therapy at ASTRO 2018.

Feature | Stereotactic Body Radiation Therapy (SBRT) | October 23, 2018 | By Greg Freiherr
With its shorter course of treatment, stereotactic body radiation therapy (SBRT) has long been preferred for patients...
CyberKnife System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
News | Stereotactic Body Radiation Therapy (SBRT) | September 27, 2018
September 27, 2018 — Accuray Inc. announced that published data from two prospective, multi-center studies using...
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
April 6, 2018 — Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people...
Age Impacts Post-treatment Mortality for Early-stage Lung Cancer Patients

Image courtesy of Henri Becquerel Cancer Center

News | Stereotactic Body Radiation Therapy (SBRT) | January 24, 2018
January 24, 2018  — A University of Colorado Cancer Center study published in the Journal of Clinical Oncology explores...
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
December 22, 2017 — The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic...
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
October 16, 2017 — Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" was presented by Parag...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
October 10, 2017 — Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer...
Adding Radiation to Chemotherapy May Dramatically Improve Survival for Advanced-Stage NSCLC Patients
News | Stereotactic Body Radiation Therapy (SBRT) | September 26, 2017
September 26, 2017 — Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
July 5, 2017 — A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to...